Efeito de diferentes doses de L-arginina em ratos após a quimioterapia com 5-Fluorouracil

Abstract

L-arginine has been used as a dietary supplement to minimize the side effects of chemotherapy, but it is not fully elucidated its actions and nor the ideal dose that can minimize the side effects. The objective of this study was to evaluate the effect of L-arginine supplementation on the formation of micronuclei in 70 Wistar rats after chemotherapy with 5-FU divided into 7 batches (10 male rats weighing 200 g/batch): LC water ad libitum; LArg2% and LArg4% mice fed commercial feed and 2% and 4% of L-arginine in water ad libitum, respectively; LC rats fed commercial feed, water ad libitum and a dose of 50 mg cyclophosphamide/kg; L5-FU rats fed commercial feed, water ad libitum and a dose of 200 mg of 5-FU/kg was applied; LArg2%+5-FU and LArg4%+5-FU rats fed commercial feed, 2% and 4% L-arginine were added in water ad libitum, respectively, and a dose of 200 mg of 5-FU/Kg. The mice were sacrificed 72 hours after the application of the chemotherapeutics to evaluate the formation of micronuclei. In the data analysis, one-way ANOVA was applied and followed by the Tukey test at 5%. Mice supplemented ad libitum with 2% and 4% L-arginine showed a reduction (P < 0.05) in the formation of micronuclei in bone marrow cells after chemotherapy, indicating that these supplements minimize the mutagenic effect of 5-FU.